AbbVie (ABBV) earnings, Jul 31, 2026: EPS +23%, stock −2.5%
In brief
AbbVie reported on Jul 31, 2026. Earnings per share changed +23% year over year, 1.2% above the estimate; revenue +10%. The stock opened with a −1.9% gap and closed the day −2.5% (Jul 31, 2026). The stock is now 4.8% below its 52-week high, +35.2% over 12 months. Next report: Feb 3, 2027.
EPS vs estimate+1.2%
EPS, YoY+23%
Revenue, YoY+10%
Gap · day−1.9% · −2.5%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Jul 31, 2026 | −1.9% | −2.5% |
Next-quarter estimates, ratings and the ABBV chart are in the terminal.
Open the terminalFAQ
When is AbbVie's next earnings report?
Feb 3, 2027. The date comes from daily data and is corrected if the company moves it.
How did AbbVie stock react to the report?
Opening gap −1.9%, day's result −2.5%.
Did AbbVie's earnings grow?
Earnings per share rose 23% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.